首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Monaldi archives for chest disease

缩写:

ISSN:1122-0643

e-ISSN:2532-5264

IF/分区:0.8/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1018条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Anastasiia Russkikh,Oleksandr Korotych,Yuliia Sereda et al. Anastasiia Russkikh et al.
Treatment outcomes for Multidrug/Rifampicin-Resistant Tuberculosis (MDR/RR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) remain poor across the globe and in the Russian Federation. Treatment of XDR-TB is challenging for programme...
Lilit Khachatryan,Ruzanna Grigoryan,Andrei Dadu et al. Lilit Khachatryan et al.
Rifampicin-Resistant/Multidrug-Resistant Tuberculosis (RR/MDR-TB) is recognized as a major public health concern globally. In Armenia, the proportion of RR/MDR-TB is increasing among all people affected with TB. We conducted a nationwide co...
Saulius Diktanas,Oleksandr Korotych,Yuliia Sereda et al. Saulius Diktanas et al.
The global proportion of successful treatment outcomes of Multidrug-Resistant/Rifampicin-Resistant Tuberculosis (MDR/RR-TB) remains unacceptably low. Time to culture conversion is important in making treatment-related decisions and is used ...
Valeriu Plesca,Ana Ciobanu,Yuliia Sereda et al. Valeriu Plesca et al.
The Republic of Moldova is among the 30 Rifampicin-Resistant and/or Multidrug-Resistant (RR/MDR) Tuberculosis (TB) high burden countries in the world. Despite free TB diagnostics and treatment, TB patients face substantial economic losses a...
Mariana Buziashvili,Hayk Davtyan,Yuliia Sereda et al. Mariana Buziashvili et al.
Considering the complexity of second-line anti-tuberculosis (TB) treatment regimens, the management of drug-resistant TB (DR-TB) in Georgia remains a major challenge. Since the introduction of new and repurposed anti-TB medications, the imp...
Lilit Gevorgyan,Ruzanna Grigoryan,Kostyantyn Dumchev et al. Lilit Gevorgyan et al.
To evaluate factors associated with tuberculosis (TB) treatment outcomes in human Immunodeficiency Virus-Associated (HIV) TB patients in Armenia, we conducted a nation-wide cohort study using routine programmatic data of all HIV-associated ...
Vera Auchynka,Ajay M V Kumar,Hennadz Hurevich et al. Vera Auchynka et al.
To address the sub-optimal treatment outcomes among patients with multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the National TB Programme in Belarus started using new drugs such as bedaquiline and delama...
Varvara Solodovnikova,Ajay M V Kumar,Hennadz Hurevich et al. Varvara Solodovnikova et al.
There is limited evidence describing the safety and effectiveness of bedaquiline and delamanid containing regimens in children and adolescents with Multidrug-Resistant Tuberculosis (MDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-T...
Simone Salvitti,Elena Repossini Simone Salvitti
Early physiotherapy (EP) programs on critically ill patients in the intensive care unit (ICU) have proven to be safe, feasible and effective. However, despite being considered by all the professionals involved as a fundamental aspect of int...